BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 21412935)

  • 1. HIV sexual transmission and microbicides.
    Ariën KK; Jespers V; Vanham G
    Rev Med Virol; 2011 Mar; 21(2):110-33. PubMed ID: 21412935
    [TBL] [Abstract][Full Text] [Related]  

  • 2. siRNA-based topical microbicides targeting sexually transmitted infections.
    Katakowski JA; Palliser D
    Curr Opin Mol Ther; 2010 Apr; 12(2):192-202. PubMed ID: 20373263
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current concepts for PrEP adherence in the PrEP revolution: from clinical trials to routine practice.
    Haberer JE
    Curr Opin HIV AIDS; 2016 Jan; 11(1):10-7. PubMed ID: 26633638
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Welcome to the preexposure prophylaxis revolution.
    Baeten J; McCormack S
    Curr Opin HIV AIDS; 2016 Jan; 11(1):1-2. PubMed ID: 26633637
    [No Abstract]   [Full Text] [Related]  

  • 5. Statistical issues in trials of preexposure prophylaxis.
    Dunn DT; Glidden DV
    Curr Opin HIV AIDS; 2016 Jan; 11(1):116-21. PubMed ID: 26545264
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Uptake of biomedical interventions for prevention of sexually transmitted HIV.
    Abbas UL
    Curr Opin HIV AIDS; 2011 Mar; 6(2):114-8. PubMed ID: 21505385
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PrEP: why are we waiting?
    Lancet HIV
    Lancet HIV; 2015 Oct; 2(10):e401. PubMed ID: 26423641
    [No Abstract]   [Full Text] [Related]  

  • 8. Fatal attraction: sex, sexually transmitted infections and HIV-1.
    Chan DJ
    Int J STD AIDS; 2006 Oct; 17(10):643-51. PubMed ID: 17059632
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alginate microbead-encapsulated silver complexes for selective delivery of broad-spectrum silver-based microbicides.
    Damelin LH; Fernandes MA; Tiemessen CT
    Int J Antimicrob Agents; 2015 Oct; 46(4):394-400. PubMed ID: 26184337
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Communicating about microbicides with women in mind: tailoring messages for specific audiences.
    Sidibe S; Pack AP; Tolley EE; Ryan E; Mackenzie C; Bockh E; Githuka G
    J Int AIDS Soc; 2014; 17(3 Suppl 2):19151. PubMed ID: 25224612
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiretroviral Medications for the Prevention of HIV Infection: A Clinical Approach to Preexposure Prophylaxis, Postexposure Prophylaxis, and Treatment as Prevention.
    Heendeniya A; Bogoch II
    Infect Dis Clin North Am; 2019 Sep; 33(3):629-646. PubMed ID: 31239092
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of topical microbicides to prevent the sexual transmission of HIV.
    Buckheit RW; Watson KM; Morrow KM; Ham AS
    Antiviral Res; 2010 Jan; 85(1):142-58. PubMed ID: 19874851
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibiting sexual transmission of HIV-1 infection.
    Shattock RJ; Moore JP
    Nat Rev Microbiol; 2003 Oct; 1(1):25-34. PubMed ID: 15040177
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ending sexual HIV transmission: lessons learned from perinatal HIV.
    Weber S; Grant RM
    J Assoc Nurses AIDS Care; 2015; 26(5):520-5. PubMed ID: 26096627
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinical update.
    Haddow L; Herbert S
    Sex Transm Infect; 2015 Mar; 91(2):150. PubMed ID: 25698792
    [No Abstract]   [Full Text] [Related]  

  • 16. First real success for anti-HIV gel: a new start for HIV microbicides?
    Ariën KK; Vanham G
    Future Microbiol; 2010 Nov; 5(11):1621-3. PubMed ID: 21133683
    [No Abstract]   [Full Text] [Related]  

  • 17. Microbicides to prevent HIV transmission: overcoming obstacles to chemical barrier protection.
    Dhawan D; Mayer KH
    J Infect Dis; 2006 Jan; 193(1):36-44. PubMed ID: 16323129
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Planning for HIV preexposure prophylaxis introduction: lessons learned from contraception.
    Delany-Moretlwe S; Mullick S; Eakle R; Rees H
    Curr Opin HIV AIDS; 2016 Jan; 11(1):87-93. PubMed ID: 26575146
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The future of microbicides.
    Omar RF; Bergeron MG
    Int J Infect Dis; 2011 Oct; 15(10):e656-60. PubMed ID: 21705253
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vaccines and microbicides preventing HIV-1, HSV-2, and HPV mucosal transmission.
    Nikolic DS; Piguet V
    J Invest Dermatol; 2010 Feb; 130(2):352-61. PubMed ID: 19829304
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.